EP
GH icon

Edgestream Partners’s Guardant Health GH Stock Holding History

Edgestream Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,257
Closed -$2.98M – 1033
2026
Q1 		$2.98M Buy
32,257
+24,606
+322% +$2.47M 0.1% 385
2025
Q4 		$781K Sell
7,651
-30,949
-80% -$2.77M 0.02% 741
2025
Q3 		$2.41M Sell
38,600
-11,919
-24% -$648K 0.07% 475
2025
Q2 		$2.63M Buy
50,519
+30,094
+147% +$1.34M 0.07% 463
2025
Q1 		$870K Buy
+20,425
New +$881K 0.03% 626
2024
Q3 		– Sell
-96,513
Closed -$2.79M – 926
2024
Q2 		$2.79M Buy
96,513
+49,574
+106% +$1.15M 0.13% 247
2024
Q1 		$968K Buy
46,939
+37,085
+376% +$795K 0.05% 511
2023
Q4 		$267K Buy
+9,854
New +$258K 0.02% 743

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Edgestream Partners's GH Position: Q2 2026 in Review

Edgestream Partners sold out of Guardant Health (GH) in Q2 2026, closing a stake of 32,257 shares — an estimated $2.98M sold.

Edgestream Partners first reported a position in GH in Q4 2023 and held it in 8 quarters. The position peaked at $2.98M in Q1 2026. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Edgestream Partners reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 32,257 Guardant Health shares in Q2 2026, an estimated $2.98M.
  • Edgestream Partners first reported a position in Guardant Health in Q4 2023 and held it in 8 quarters.
  • Edgestream Partners's Guardant Health position peaked at $2.98M in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.